Expression of CD64 (FcγRI) in skin of patients with acute GVHD

被引：2
|
作者：
van Royen-Kerkhof, A. [1 ,2 ]
Walraven, V. [2 ]
Sanders, E. A. M. [2 ]
de Weger, R. [3 ]
van Wichen, D. F. [3 ]
de Koning, E. [3 ]
Thepen, T. [4 ]
van de Winkel, J. G. J. [1 ,5 ]
Leusen, J. H. W. [1 ]
机构：
[1] Univ Med Ctr Utrecht, Immunotherapy Lab, Dept Immunol, NL-3584 EA Utrecht, Netherlands
[2] Univ Med Ctr Utrecht, Dept Pediat Immunol, NL-3584 EA Utrecht, Netherlands
[3] Univ Med Ctr Utrecht, Dept Mol Pathol, NL-3584 EA Utrecht, Netherlands
[4] Fraunhofer IME, Dept Pharmaceut Prod Dev, Aachen, Germany
[5] Genmab, Utrecht, Netherlands
来源：
BONE MARROW TRANSPLANTATION | 2011年 / 46卷 / 12期
关键词：
graft-versus-host disease; IgG receptor; CD64; immunotherapy; macrophage; VERSUS-HOST-DISEASE; DENDRITIC CELLS; MACROPHAGES; RECEPTOR; TRANSPLANTATION; POLYMORPHISM;
D O I：
10.1038/bmt.2010.337
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
GVHD remains a major problem in allo-SCT. We explored the presence of APC in skin biopsies of GVHD patients, using the IgG receptor CD64 expression as a hallmark for activated APC. By immunohistochemistry we demonstrated CD64 to be upregulated on host APC in skin biopsies of patients with acute GVHD and, less prominently, in chronic GVHD. Double staining for CD32 polymorphism revealed CD64-positive cells to be mainly of host origin. The majority of CD64-positive cells coexpressed CD68, indicating a macrophage phenotype. Given its very restricted cellular distribution, CD64 may represent an excellent target for APC-directed therapies in GVHD. Bone Marrow Transplantation (2011) 46, 1566-1569; doi:10.1038/bmt.2010.337; published online 17 January 2011
引用
收藏
页码：1566 / 1569
页数：4
相关论文
共 50 条
  • [1] Expression of CD64 (FcγRI) in skin of patients with acute GVHD
    A van Royen-Kerkhof
    V Walraven
    E A M Sanders
    R de Weger
    D F van Wichen
    E de Koning
    T Thepen
    J G J van de Winkel
    J H W Leusen
    Bone Marrow Transplantation, 2011, 46 : 1566 - 1569
  • [2] FcγRI (CD64): An identity card for intestinal macrophages
    De Calisto, Jaime
    Villablanca, Eduardo J.
    Mora, J. Rodrigo
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2012, 42 (12) : 3136 - 3140
  • [3] FcγRI (CD64) resides constitutively in lipid rafts
    Beekman, Jeffrey A.
    van der Linden, Joke A.
    van de Winkel, Jan G. J.
    Leusen, Jeanette H. W.
    IMMUNOLOGY LETTERS, 2008, 116 (02) : 149 - 155
  • [4] Cell surface expression of FcγRI (CD64) on neutrophils and monocytes in patients with influenza A, with and without complications
    Fjaertoft, G
    Pauksen, K
    Håkansson, L
    Xu, SY
    Venge, P
    SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2005, 37 (11-12) : 882 - 889
  • [5] Expression of the phagocyte receptor CD64 (Fc gamma RI) on neutrophils during infection.
    Fjaertoft, G
    Ewald, U
    Foucard, T
    Hakansson, L
    Venge, P
    PEDIATRIC RESEARCH, 1996, 39 (04) : 1752 - 1752
  • [6] CD64 (FcγRI) is a novel receptor for HCV entry into monocytes
    Cunningham, Morven E.
    Wright, Joseph D.
    Wong, Joshua L.
    Waters, Jennifer A.
    Foster, Graham R.
    HEPATOLOGY, 2013, 58 : 928A - 928A
  • [7] Increased expression of FcγRI/CD64 on circulating monocytes parallels ongoing inflammation and nephritis in lupus
    Li, Yi
    Lee, Pui Y.
    Sobel, Eric S.
    Narain, Sonali
    Satoh, Minoru
    Segal, Mark S.
    Reeves, Westley H.
    Richards, Hanno B.
    ARTHRITIS RESEARCH & THERAPY, 2009, 11 (01)
  • [8] Increased expression of FcγRI/CD64 on circulating monocytes parallels ongoing inflammation and nephritis in lupus
    Yi Li
    Pui Y Lee
    Eric S Sobel
    Sonali Narain
    Minoru Satoh
    Mark S Segal
    Westley H Reeves
    Hanno B Richards
    Arthritis Research & Therapy, 11
  • [9] Modulation of FcγRI (CD64) ligand binding by blocking peptides of periplakin
    Beekman, JM
    Bakema, JE
    van der Linden, J
    Tops, B
    Hinten, M
    van Vugt, M
    van de Winkel, JGJ
    Leusen, JHW
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (32) : 33875 - 33881
  • [10] Effective phagocytosis and killing of Candida albicans via targeting FcγRI (CD64) or FcαRI (CD89) on neutrophils
    van Spriel, AB
    van den Herik-Oudijk, IE
    van Sorge, NM
    Vilé, HA
    van Strijp, JAG
    van de Winkel, JGJ
    JOURNAL OF INFECTIOUS DISEASES, 1999, 179 (03): : 661 - 669
12345